Appearance of a Single Amino Acid Insertion at Position 33 in HIV Type 1 Protease Under a Lopinavir-Containing Regimen, Associated with Reduced Protease Inhibitor Susceptibility-Reference-Cited by-同舟云学术

Appearance of a Single Amino Acid Insertion at Position 33 in HIV Type 1 Protease Under a Lopinavir-Containing Regimen, Associated with Reduced Protease Inhibitor Susceptibility

Published:2011-11 Issue:11 Volume:27 Page:1223-1229
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Magiorkinis Emmanouil¹,Paraskevis Dimitrios¹,Detsika Maria G.¹,Lu Liangjun²,Magiorkinis Gkikas¹,Lazanas Marios³,Imbrechts Stijn⁴,Van Laethem Kristel⁴,Vandamme Anne-Mieke⁴,Pilot-Matias Tami²,Molla Akhteruzzaman²,Camacho Ricardo J.⁵⁶,Hatzakis Angelos¹

Affiliation:

1. Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece.

2. Antiviral Research, Abbott Global Pharmaceutical R&D, Abbott Park, Illinois.

3. Red Cross General Hospital, Athens, Greece.

4. Clinical and Epidemiological Virology, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.

5. Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.

6. Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2010.0275

Reference22 articles.

1. Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility

2. Functional Correlates of Insertion Mutations in the Protease Gene of Human Immunodeficiency Virus Type 1 Isolates from Patients

3. Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure

4. A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog Resistance